The CSS Biobank is led by researchers from King’s College London.
The aim of the COVID Symptom Study (CSS) Biobank is to understand the impact and effects of COVID-19 and how these may be linked with health conditions and other genetic and environmental factors.
CSS Biobank participants were invited to join the Biobank in 2020 and 2021 from the (then) ZOE COVID Symptom Study to allow the collection of additional clinical and questionnaire data, and samples such as blood. The CSS Biobank is separate to the ZOE COVID Symptom Study.
We want to understand how the body responds to the coronavirus that causes COVID-19, and how the COVID-19 affects the body in the long-term. We also want to link to official health, education and environmental records in order to have the best possible data for our COVID-19 research.
More information about the CSS Biobank and how it works is available in our Volunteer Information Sheet.
Participants need to read the Volunteer Information Sheet and complete the online Consent Form in order to take part in the CSS Biobank. Participation is by invitation only.